Article ; Online: Pathology of TB/COVID-19 Co-Infection: The phantom menace.
Tuberculosis (Edinburgh, Scotland)
2020 Volume 126, Page(s) 102020
Abstract: Tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are currently the two main causes of death among infectious diseases. There is an increasing number of studies trying to elucidate the interactions between Mycobacterium tuberculosis and SARS-CoV- ... ...
Abstract | Tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are currently the two main causes of death among infectious diseases. There is an increasing number of studies trying to elucidate the interactions between Mycobacterium tuberculosis and SARS-CoV-2. Some of the first case reports point to a worsening of respiratory symptoms in co-infected TB/COVID-19 individuals. However, data from the cohort studies has shown some conflicting results. This study proposes to conduct a systematic review on the current literature on TB/COVID-19 co-infection cohorts, evaluating clinical and epidemiological data, focusing on its implications to the immune system. From an immunological perspective, the TB/COVID-19 co-infection has the potential to converge in a "perfect storm". The disorders induced by each pathogen to the immunomodulation tend to induce an unbalanced inflammatory response, which can promote the progression and worsening of both diseases. Understanding the nature of the interactions between M. tuberculosis and SARS-CoV-2 will be crucial for the development of therapeutic strategies against co-infection. |
---|---|
MeSH term(s) | Animals ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/therapy ; COVID-19/virology ; Coinfection ; Disease Progression ; Host-Pathogen Interactions ; Humans ; Inflammation Mediators/immunology ; Lung/immunology ; Lung/microbiology ; Lung/virology ; Mycobacterium tuberculosis/immunology ; Mycobacterium tuberculosis/pathogenicity ; Prognosis ; SARS-CoV-2/immunology ; SARS-CoV-2/pathogenicity ; Signal Transduction ; Tuberculosis, Pulmonary/epidemiology ; Tuberculosis, Pulmonary/immunology ; Tuberculosis, Pulmonary/microbiology ; Tuberculosis, Pulmonary/therapy |
Chemical Substances | Inflammation Mediators |
Language | English |
Publishing date | 2020-11-17 |
Publishing country | Scotland |
Document type | Journal Article ; Systematic Review |
ZDB-ID | 2046804-0 |
ISSN | 1873-281X ; 1472-9792 |
ISSN (online) | 1873-281X |
ISSN | 1472-9792 |
DOI | 10.1016/j.tube.2020.102020 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh II Zs.221: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.